Physician profile
Brian P Witwer
NPI 1982698148
$5,935.40
in general payments reported to CMS, 2019-2025
12 companies · $411 in 2025
The $411 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,700 · 2020: $2,315 · 2021: $92.92 · 2022: $1,087 · 2023: $140 · 2024: $189 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $1,669.03 | 2019-2020 | |
| Boston Scientific Corporation | $1,593.82 | 2019-2025 | General - Dbs |
| Globus Medical, INC. | $1,242.34 | 2020 | |
| Seaspine Orthopedics Corporation | $767.10 | 2022 | |
| Spineology INC. | $317.74 | 2019-2020 | |
| Kls-Martin L.P. | $163.98 | 2025 | |
| Orthofix Medical, INC. | $94.09 | 2022 | |
| Integra Lifesciences Corporation | $44.20 | 2021-2023 | Codman Hakim, Cusa Clarity, Codman Certas |
| Abbott Laboratories | $15.04 | 2020 | |
| Stryker Corporation | $13.72 | 2025 | Mako |
| Augmedics INC. | $10.21 | 2021 | |
| Brainlab, INC. | $4.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Witwer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.